Koninklijke Philips | PHG - Assets


Koninklijke Philips reported EUR27.27B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Baxter International USD 19.85B 209M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Boston Scientific USD 44.35B 678M Mar/2026
Danaher USD 83.54B 80M Mar/2026
Demant DKK 39.07B 6.43B Dec/2025
Dexcom USD 6.63B 293.4M Mar/2026
Edwards Lifesciences USD 13.32B 376M Mar/2026
Fresenius EUR 41.4B 1.07B Dec/2025
General Electric Aerospace USD 127.67B 773M Jun/2026
Getinge SEK 57.37B 6.55B Jun/2026
Globus Medical USD 5.44B 136.79M Mar/2026
GN Store Nord DKK 28.56B 671M Mar/2026
Hitachi JPY 15.04T 356.53B Mar/2026
Idexx Laboratories USD 3.39B 34.74M Mar/2026
Insulet USD 2.99B 203.2M Mar/2026
Integra LifeSciences USD 3.58B 24.28M Mar/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
J&J USD 200.89B 1.68B Mar/2026
Koninklijke Philips EUR 27.27B 4.38B Mar/2026
Medtronic USD 91.48B 139M Dec/2025
Philips EUR 27.27B 322M Mar/2026
ResMed USD 8.78B 280.91M Mar/2026
Smith & Nephew USD 10.69B 150M Dec/2025
Steris USD 10.74B 145.8M Mar/2026
Stryker USD 46.29B 1.55B Mar/2026
Teleflex USD 6.78B 164.24M Mar/2026
Terumo JPY 2.31T 55.3B Mar/2026
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026